Showing results (421-430 of 454) with videos related to
Sort By:
Pageof 46
The Journal of Infectious Diseases|May 17, 2021
Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis BYao-Chun Hsu, Ming-Lun Yeh, Grace Lai-Hung Wong, et al.HGG Advances|June 30, 2024
Stratified analyses refine association between TLR7 rare variants and severe COVID-19Jannik Boos, Caspar I van der Made, Gayatri Ramakrishnan, et al.The Lancet. Gastroenterology & Hepatology|August 14, 2017
Safety and efficacy of an 8-week regimen of grazoprevir plus ruzasvir plus uprifosbuvir compared with grazoprevir plus elbasvir plus uprifosbuvir in participants without cirrhosis infected with hepatitis C virus genotypes 1, 2, or 3 (C-CREST-1 and C-CREST-2, part A): two randomised, phase 2, open-label trialsEdward J Gane, Stephen Pianko, Stuart K Roberts, et al.Journal of Hepatology|June 28, 2011
Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patientsAlexander J Thompson, Paul J Clark, Abanish Singh, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 4, 2020
Hepatitis B Core-Related Antigen to Indicate High Viral Load: Systematic Review and Meta-Analysis of 10,397 Individual ParticipantsKyoko Yoshida, Alice Desbiolles, Sarah F Feldman, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 6, 2023
Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection and COVID-19 disease severityPhilip R Tedbury, Candela Manfredi, Frauke Degenhardt, et al.Journal of Hepatology|July 25, 2020
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitisRong Fan, George Papatheodoridis, Jian Sun, et al.Gastroenterology|April 20, 2010
Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virusAlexander J Thompson, Andrew J Muir, Mark S Sulkowski, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 3, 2025
Risk Factors of Metabolic Dysfunction-associated Steatotic Liver Disease in a Cohort of Patients With Chronic Hepatitis BMaria Kalafateli, Roberta Forlano, Eleanor Barnes, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 9, 2021
Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis BHeejoon Jang, Jun Sik Yoon, Soo Young Park, et al.Pageof 46